1. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts

   Valent, P., Akin, C., Hartmann, K., Nilsson, G., Reiter, A., Hermine, O., Sotlar, K., Sperr, W. R., Escribano, L., George, T., Kluin-Nelemans, H. C., Ustun, C., Triggiani, M., Brockow, K., Gotlib, J., Orfao, A., Kovanen, P. T., Hadzijusufovic, E., Sadovnik, I., Horny, H-P., Arock, M., Schwartz, L. B., Austen, K. F., Metcalfe, D. D. & Galli, S. J., 2020, In : Theranostics. 10, 23, p. 10743-10768 26 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions

   Valent, P., Akin, C., Bonadonna, P., Brockow, K., Niedoszytko, M., Nedoszytko, B., Butterfield, J. H., Alvarez-Twose, I., Sotlar, K., Schwaab, J., Jawhar, M., Reiter, A., Castells, M., Sperr, W. R., Kluin-Nelemans, H. C., Hermine, O., Gotlib, J., Zanotti, R., Broesby-Olsen, S., Horny, H-P., Triggiani, M., Siebenhaar, F., Orfao, A., Metcalfe, D. D., Arock, M. & Hartmann, K., 1-Aug-2020, In : Journal of Allergy and Clinical Immunology. 146, 2, p. 300-306 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

   Trizuljak, J., Sperr, W. R., Nekvindova, L., Elberink, H. O., Gleixner, K., Gorska, A., Lange, M., Hartmann, K., Illerhaus, A., Bonifacio, M., Perkins, C., Elena, C., Malcovati, L., Fortina, A. B., Shoumariyeh, K., Jawhar, M., Zanotti, R., Bonadonna, P., Caroppo, F., Zink, A., Triggiani, M., Parente, R., von Bubnoff, N., Yavuz, A. S., Hagglund, H., Mattsson, M., Panse, J., Jaekel, N., Kilbertus, A., Hermine, O., Arock, M., Fuchs, D., Sabato, V., Brockow, K., Bretterklieber, A., Niedoszytko, M., van Anrooij, B., Reiter, A., Gotlib, J., Kluin-Nelemans, H. C., Mayer, J., Doubek, M. & Valent, P., Aug-2020, In : Allergy. 75, 8, p. 1927-1938 12 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis

   Hartmann, K., Gotlib, J., Akin, C., Hermine, O., Awan, F. T., Hexner, E., Mauro, M. J., Menssen, H. D., Redhu, S., Knoll, S., Sotlar, K., George, T. I., Horny, H-P., Valent, P., Reiter, A. & Kluin-Nelemans, H. C., 1-Aug-2020, In : Journal of Allergy and Clinical Immunology. 146, 2, p. P356-366.E4 15 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial

   Roider, T., Wang, X., Huettl, K., Mueller-Tidow, C., Klapper, W., Rosenwald, A., Stewart, J. P., de Castro, D. G., Dreger, P., Hermine, O., Kluin-Nelemans, H. C., Grabe, N., Dreyling, M., Pott, C., Ott, G., Hoster, E. & Dietrich, S., 15-Aug-2020, In : International Journal of Cancer. 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (393) »

1. Mastocytosis screening: use methylimidazole acetic acid in older overweight people

   Byrthe Vos, Eveline Veer, van der, Pieter Voorst Vader ,van, Andre Mulder, Sicco Heide, van der, Suzanne Boezerooij-Arends, Johanna Kluin-Nelemans, Hanneke Oude Elberink, Jan Monchy ,de & Jasper Doormaal, van

   13/08/2014

   1 item of Media coverage

   Press/Media: Research › Popular

View all (1) »